Common Respiratory Viruses May Accelerate ALS Progression
Study shows immune responses to flu and COVID-19 trigger lasting inflammation in the spine, hastening onset/progression of amyotrophic lateral sclerosis (ALS).
Study shows immune responses to flu and COVID-19 trigger lasting inflammation in the spine, hastening onset/progression of amyotrophic lateral sclerosis (ALS).
Small cell lung cancer patients receiving focused treatment lived a median of 17 months compared to nine months with whole brain radiation.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
Patients with chronic bronchitis experienced better quality of life and fewer severe hospitalizations after Metered CryoSpray (MCS) therapy.
Global analysis of more than 60,000 RSV viral sequences reveals that resistance to monoclonal antibodies remains rare.
Two studies link fine particulate matter from wildfires to increased hospital admissions and lower lung cancer survival.
The same technology used to deliver mRNA in COVID-19 vaccines is being used to target a type of immune cell that can help tumors evade the body's defenses.
New 3D modeling reveals that unsteady airflow over the soft palate drives loud snoring sounds, pointing toward targeted therapies.